Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Parul Chaudhuri

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
Clinical Advances in Hematology & Oncology : H&O|March 8, 2019
Adjuvant therapy in high-risk prostate cancerJeffrey Shevach, Parul Chaudhuri, Alicia K Morgans
Pediatrics in Review|January 3, 2019
Rationale for the Immunization Schedule: Why Is It the Way It Is?Varun U Shetty, Parul Chaudhuri, Camille Sabella
Clinical Oncology and Research|April 16, 2019
Osteoclast inhibitor treatment among men with metastatic castration-resistant prostate cancerDaniel Sonnenburg, Parul Chaudhuri, Amy J Graves, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Clinical Advances in Hematology & Oncology : H&O|March 8, 2019
Adjuvant therapy in high-risk prostate cancerJeffrey Shevach, Parul Chaudhuri, Alicia K Morgans
Pediatrics in Review|January 3, 2019
Rationale for the Immunization Schedule: Why Is It the Way It Is?Varun U Shetty, Parul Chaudhuri, Camille Sabella
Clinical Oncology and Research|April 16, 2019
Osteoclast inhibitor treatment among men with metastatic castration-resistant prostate cancerDaniel Sonnenburg, Parul Chaudhuri, Amy J Graves, et al.
Pageof 1